RxNorm Semantic Concepts Index - 322
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "322".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 322 | Myokinase | Designated preferred name (PT) | NO | |
| RxCUI: 322 | Myokinase | Full form of descriptor (FN) | NO | |
| RxCUI: 322 | Myokinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3220 | dU - Deoxyuridine | Designated preferred name (PT) | NO | |
| RxCUI: 3220 | dU - Deoxyuridine | Full form of descriptor (FN) | NO | |
| RxCUI: 3220 | dU - Deoxyuridine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 32201 | O-Acetylhomoserine (thiol)-lyase | Designated preferred name (PT) | NO | |
| RxCUI: 32201 | O-Acetylhomoserine (thiol)-lyase | Full form of descriptor (FN) | NO | |
| RxCUI: 32210 | O-demethylpuromycin methyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 32210 | O-demethylpuromycin methyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 322154 | Fondaparinux sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 322154 | Fondaparinux sodium | Designated preferred name (PT) | YES | |
| RxCUI: 322154 | Fondaparinux sodium | Full form of descriptor (FN) | YES | |
| RxCUI: 322155 | Arixtra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 322165 | thiosalicylic acid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 322167 | Solifenacin | Full form of descriptor (FN) | YES | |
| RxCUI: 322167 | Solifenacin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 322167 | Solifenacin | Designated preferred name (PT) | YES | |
| RxCUI: 322167 | Solifenacin | Full form of descriptor (FN) | YES | |
| RxCUI: 322167 | Solifenacin | Designated preferred name (PT) | YES | |
| RxCUI: 322248 | Tenofovir disoproxil fumarate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 322248 | Tenofovir disoproxil fumarate | Designated preferred name (PT) | YES | |
| RxCUI: 322248 | Tenofovir disoproxil fumarate | Full form of descriptor (FN) | YES | |
| RxCUI: 322249 | Frovatriptan succinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 322249 | Frovatriptan succinate | Designated preferred name (PT) | YES | |
| RxCUI: 322249 | Frovatriptan succinate | Full form of descriptor (FN) | YES | |
| RxCUI: 322250 | Frova | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 32233 | Cystathionine gamma-synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 32233 | Cystathionine gamma-synthase | Designated preferred name (PT) | NO | |
| RxCUI: 32233 | Cystathionine gamma-synthase | Full form of descriptor (FN) | NO | |
| RxCUI: 3226 | Dequalinium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 3226 | Dequalinium | Designated preferred name (PT) | NO | |
| RxCUI: 3226 | Dequalinium | Full form of descriptor (FN) | NO | |
| RxCUI: 3226 | Dequalinium | Designated preferred name (PT) | NO | |
| RxCUI: 3226 | Dequalinium | Full form of descriptor (FN) | NO | |
| RxCUI: 3228 | Chondroitin sulfate B | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3228 | Chondroitin sulfate B | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 3228 | Chondroitin sulfate B | Designated preferred name (PT) | NO | |
| RxCUI: 3228 | Chondroitin sulfate B | Full form of descriptor (FN) | NO | |
| RxCUI: 3228 | Chondroitin sulfate B | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 32286 | Octanol dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 32286 | Octanol dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 322901 | Ceftobiprole | Designated preferred name (PT) | NO | |
| RxCUI: 322901 | Ceftobiprole | Full form of descriptor (FN) | NO | |
| RxCUI: 322901 | Ceftobiprole | Designated preferred name (PT) | NO | |
| RxCUI: 322901 | Ceftobiprole | Full form of descriptor (FN) | NO | |
| RxCUI: 322974 | Technetium (99m-Tc) depreotide | Designated preferred name (PT) | NO | |
| RxCUI: 322974 | Technetium (99m-Tc) depreotide | Full form of descriptor (FN) | NO | |
| RxCUI: 322982 | Xigris | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 32299 | D-octopine synthase | Designated preferred name (PT) | NO | |
| RxCUI: 32299 | D-octopine synthase | Full form of descriptor (FN) | NO | |
| RxCUI: 32299 | D-octopine synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 32299 | D-octopine synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 32299 | D-octopine synthase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |